Stereotactic ablative body radiotherapy
Showing 1 - 25 of >10,000
Solid Tumor Spine Metastases Trial in Dublin (Radiation: image guided dose escalated SABR using a simultaneous integrated boost
Not yet recruiting
- Solid Tumor Spine Metastases
- Radiation: image guided dose escalated SABR using a simultaneous integrated boost (SIB)
-
Dublin, Ireland
- +1 more
Oct 16, 2023
Proton-Based Stereotactic Ablative Body Radiotherapy for
Active, not recruiting
- Prostate Cancer
- Proton beam
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 26, 2022
Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate SBRT (stereotactic body radiation therapy) with focal boost
-
Madrid, SpainLa Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023
Radiation-Induced Injury to Airways and Pulmonary Vasculature in
Recruiting
- Lung Cancer
- Thoracic Cancer
-
Dallas, TexasUT Southwestern Cancer Center
Jul 11, 2022
Metastatic Tumors Trial in Prince George (Stereotactic Ablative Body Radiotherapy)
Active, not recruiting
- Metastatic Tumors
- Stereotactic Ablative Body Radiotherapy
-
Prince George, British Columbia, CanadaBC Cancer
Apr 6, 2022
Breast Cancer, Breast Cancer Female, Breast Adenocarcinoma Trial in Tampa (Standard of Care Schedule Variation: SABR,
Terminated
- Breast Cancer
- +2 more
- Standard of Care Schedule Variation: SABR
- Breast-conserving Surgery
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Apr 26, 2022
NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))
Completed
- Non-small Cell Lung Cancer
- Pembrolizumab
- Radiotherapy (SABR)
-
Melbourne, Victoria, Australia
- +1 more
May 23, 2022
Prostate Cancer Trial (SUPR-SABR treatment)
Not yet recruiting
- Prostate Cancer
- SUPR-SABR treatment
- (no location specified)
Dec 20, 2022
Prostate Cancer Trial in Toronto (Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5)
Active, not recruiting
- Prostate Cancer
- Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5
-
Toronto, Ontairo, CanadaSunnybrook Health Sciences Center
Sep 27, 2022
Prostate Cancer Trial in Toronto (SpaceOAR)
Recruiting
- Prostate Cancer
- SpaceOAR
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Oct 25, 2022
Lung Metastases, Colorectal Cancer Metastatic Trial in Amsterdam (Minimally invasive pulmonary metastasectomy, Stereotactic
Not yet recruiting
- Lung Metastases
- Colorectal Cancer Metastatic
- Minimally invasive pulmonary metastasectomy
- Stereotactic ablative radiotherapy
-
Amsterdam, NetherlandsAmsterdam University Medical Center (AUMC)
Apr 10, 2023
Pancreatic Adenocarcinoma Trial in United States (Durvalumab, Stereotactic Ablative Body Radiotherapy (SABR))
Active, not recruiting
- Pancreatic Adenocarcinoma
- Durvalumab
- Stereotactic Ablative Body Radiotherapy (SABR)
-
Los Angeles, California
- +7 more
Aug 11, 2022
Lung Tumor Malignant Trial in Milano (SBRT, Surgery)
Not yet recruiting
- Lung Neoplasm Malignant
- SBRT
- Surgery
-
Milano, MI, ItalyIstituto Europeo di Oncologia IRCCS
Jul 26, 2023
Cancer Trial (CPAP)
Not yet recruiting
- Cancer
- CPAP
- (no location specified)
May 29, 2022
Prostate Cancer Trial (Urolift, SABR)
Not yet recruiting
- Prostate Cancer
- Urolift
- SABR
- (no location specified)
Jun 23, 2022
Malignant Prostate Tumor Trial in Rochester (procedure, radiation, other)
Not yet recruiting
- Malignant Prostate Neoplasm
- Computed Tomography
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 13, 2023
Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,
Active, not recruiting
- Child-Pugh Class A
- +2 more
- Stereotactic Body Radiation Therapy
- +3 more
-
Palo Alto, California
- +1 more
Sep 9, 2022
Prostate Cancer, Cancer of Prostate, Prostate Adenocarcinoma Trial (Stereotactic Ablative Body Radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Stereotactic Ablative Body Radiation
- (no location specified)
Oct 26, 2022
Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma Trial (Stereotactic Ablative Body
Not yet recruiting
- Resectable Pancreatic Adenocarcinoma
- Borderline Resectable Pancreatic Adenocarcinoma
- Stereotactic Ablative Body Radiotherapy (SABR)
- (no location specified)
Jun 16, 2021
Recurrent Head and Neck Carcinoma Trial in Houston (Intensity-Modulated Radiation Therapy, Proton Radiation, Stereotactic Body
Recruiting
- Recurrent Head and Neck Carcinoma
- Intensity-Modulated Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 16, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Sacramento (Anti-PD-L1 Monoclonal Antibody MPDL3280A,
Terminated
- Recurrent Non-Small Cell Lung Carcinoma
- Stage IV Non-Small Cell Lung Cancer
- Anti-PD-L1 Monoclonal Antibody MPDL3280A
- Stereotactic Body Radiation Therapy
-
Sacramento, CaliforniaUniversity of California Davis
Aug 2, 2022
Cancer of Pancreas Trial in Cambridge (Pre-operative stereotactic ablative body radiotherapy)
Active, not recruiting
- Cancer of Pancreas
- Pre-operative stereotactic ablative body radiotherapy
-
Cambridge, United KingdomAddenbrookes Hospital
Feb 5, 2021
Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body
Not yet recruiting
- Stage III Prostate Cancer AJCC v8
- Stage IVA Prostate Cancer AJCC v8
- External Beam Radiation Therapy
- Stereotactic Body Radiation Therapy
- (no location specified)
Jul 20, 2023
Sarcoma, Soft Tissue Trial in Orange (Pembrolizumab, Stereotactic body radiation therapy)
Recruiting
- Sarcoma, Soft Tissue
- Pembrolizumab
- Stereotactic body radiation therapy
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 9, 2022
NSCLC, NSCLC Stage IV Trial in Madison (Durvalumab, Tremelimumab, Stereotactic Body Radiotherapy)
Active, not recruiting
- Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer Stage IV
- Durvalumab
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 21, 2022